Camlin Fine Sciences schedules Q4FY26 earnings call on May 26

1 min read     Updated on 20 May 2026, 01:07 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Camlin Fine Sciences Limited has announced a conference call on May 26, 2026, to discuss the audited financial results for the quarter and year ended March 31, 2026. The meeting, scheduled for 05:00 PM IST, will be led by senior management including the Chairman and Managing Director. Investors must pre-register to join the discussion, which will cover operational and financial performance based on publicly available information.

powered bylight_fuzz_icon
40807442

*this image is generated using AI for illustrative purposes only.

Camlin Fine Sciences Limited has scheduled a conference call to discuss the operational and financial performance of the company for the quarter and year ended March 31, 2026. The interaction with investors and analysts is set to take place on Tuesday, May 26, 2026, at 05:00 PM IST. The senior management team will engage in the discussion pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Agenda and Participants

The primary focus of the call will be the audited standalone and consolidated financial results for Q4 and FY26. Discussions will be based on publicly available information, and no unpublished price-sensitive information (UPSI) is intended to be shared. The key management personnel participating in the interaction include:

Participant Designation
Mr. Ashish Dandekar Chairman & Managing Director
Mr. Nirmal Momaya Managing Director
Mr. Santosh Parab Chief Financial Officer

Conference Call Details

Investors interested in participating are requested to pre-register for the event. The access numbers for the call are provided below:

Access Type Number
Primary Number +91 22 6280 1309, +91 22 7115 8210
USA (Toll Free) 1 866 746 2133
UK (Toll Free) 0 808 101 1573
Singapore (Toll Free) 800 101 2045
Hong Kong (Toll Free) 800 964 448

The company noted that the date of the scheduled call is subject to change due to exigencies on the part of analysts, investors, or the company. Strategic Growth Advisors Pvt. Ltd. is managing the RSVP for the event.

Historical Stock Returns for Camlin Fine Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
-1.54%-2.24%+16.44%-21.69%-37.41%-24.20%

How has Camlin Fine Sciences' specialty chemicals segment performed relative to industry peers in FY26, and what growth trajectory can investors expect for FY27?

Given the global presence of toll-free access numbers from the USA, UK, Singapore, and Hong Kong, what international expansion plans or cross-border partnerships is Camlin Fine Sciences likely to announce?

How might fluctuations in raw material costs and global supply chain disruptions have impacted Camlin Fine Sciences' margins in Q4 FY26, and what mitigation strategies could management outline?

Camlin Fine Sciences Shareholders Approve Increase in Authorized Share Capital via Postal Ballot

3 min read     Updated on 09 May 2026, 08:44 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Camlin Fine Sciences Limited completed its postal ballot process with shareholders approving the increase in Authorized Share Capital and amendment to Clause V of the Memorandum of Association on May 7, 2026. Out of 111,219,615 votes polled (57.8993% of outstanding shares), 99.9899% were cast in favour. The Scrutinizer's Report dated May 8, 2026, was submitted by J. H. Ranade of JHR & Associates, Practicing Company Secretaries, Thane.

powered bylight_fuzz_icon
39785898

*this image is generated using AI for illustrative purposes only.

Camlin Fine Sciences Limited has successfully completed its postal ballot process, with shareholders approving the resolution for increase in Authorized Share Capital and consequent amendment to Clause V of the Memorandum of Association of the Company. The resolution was passed with requisite majority on May 7, 2026, being the last date of voting. The outcome was disclosed to the stock exchanges on May 8, 2026, in compliance with Regulation 44 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Postal Ballot Process Overview

The postal ballot process was initiated pursuant to a letter dated April 7, 2026, seeking consent of the members of the Company through remote e-voting. The cut-off date for determining eligible equity shareholders was Friday, April 3, 2026. The voting period commenced on Wednesday, April 8, 2026, at 9:00 a.m. (IST) and concluded on Thursday, May 7, 2026, at 5:00 p.m. (IST). Voting was conducted in electronic mode only, facilitated through the portal of National Securities Depository Limited (NSDL). The total number of shareholders on the cut-off date stood at 53,231.

Voting Results Summary

The following table presents the consolidated voting results across all shareholder categories for the resolution on increase in Authorized Share Capital:

Metric: Details
Total Shares Held: 192,091,613
Total Votes Polled: 111,219,615
% Votes Polled on Outstanding Shares: 57.8993%
Total Votes in Favour: 111,208,337
Total Votes Against: 11,278
% Votes in Favour on Votes Polled: 99.9899%
% Votes Against on Votes Polled: 0.0101%

Category-Wise Voting Breakdown

The voting participation and results varied across shareholder categories. The Promoter and Promoter Group cast all their votes in favour, while Public Institutions also voted unanimously in favour. A marginal dissent was recorded from the Public Non-Institutions category. The detailed category-wise results are as follows:

Category: Shares Held Votes Polled % Polled Votes in Favour Votes Against % in Favour % Against
Promoter & Promoter Group: 92,264,053 92,264,053 100.0000% 92,264,053 0 100.0000% 0.0000%
Public Institutions: 16,761,046 13,966,885 83.3294% 13,966,885 0 100.0000% 0.0000%
Public Non-Institutions: 83,066,514 4,988,677 6.0056% 4,977,399 11,278 99.7739% 0.2261%
Total: 192,091,613 111,219,615 57.8993% 111,208,337 11,278 99.9899% 0.0101%

Scrutinizer's Report

The Scrutinizer's Report dated May 8, 2026, was submitted by J. H. Ranade, Partner of JHR & Associates, Practicing Company Secretaries, Thane (FCS: 4317, CP: 2520), who was appointed by the Board of Directors to oversee the postal ballot voting process. The report was prepared pursuant to Section 108 and Section 110 of the Companies Act, 2013, read with Rule 20 and Rule 22 of the Companies (Management and Administration) Rules, 2014. After the close of the remote e-voting period, votes were unblocked and a detailed voting summary report was downloaded from the NSDL portal in the presence of two independent witnesses.

The ballot-wise summary of votes cast for the special resolution is presented below:

Voted in Favour:

Type of Voting: Number of Ballots Number of Valid Votes Percentage
Remote E-Voting: 226 111,208,337 99.9899%

Voted Against:

Type of Voting: Number of Ballots Number of Valid Votes Percentage
Remote E-Voting: 16 11,278 0.0101%

No invalid, less-voted, or abstained ballots were recorded. The promoter and promoter group were not identified as interested parties in the resolution. The voting results along with the Scrutinizer's Report are available on the Company's website at www.camlinfs.com . The disclosure was signed by Rahul Sawale, Company Secretary & VP Legal, on behalf of Camlin Fine Sciences Limited.

Historical Stock Returns for Camlin Fine Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
-1.54%-2.24%+16.44%-21.69%-37.41%-24.20%

How does Camlin Fine Sciences plan to utilize the increased Authorized Share Capital — through a rights issue, QIP, or preferential allotment — and what is the expected timeline for the next capital-raising action?

Could the authorized share capital increase signal an upcoming acquisition or strategic expansion in Camlin Fine Sciences' antioxidants or specialty chemicals business, and which geographies or segments are most likely targets?

How might the potential dilution from the increased share capital impact existing shareholders' earnings per share and return on equity over the next 12–24 months?

More News on Camlin Fine Sciences

1 Year Returns:-37.41%